Edwards Lifesciences en las noticias
Innovación global en cardiología estructural
Tamtam encontró 20 artículos recientes sobre Edwards Lifesciences.
- Edwards Lifesciences CVP Daniel Lippis sells $53k in stock By Investing.com
- Is Edwards Lifesciences (NYSE:EW) Entering A Stronger Phase?
- Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
- Why Edwards Lifesciences (EW) Stock Is Falling Today
- UBS reiterates Edwards Lifesciences stock rating on endpoint expectations By Investing.com
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Did FDA Approval Just Shift Edwards Lifesciences (EW) Investment Narrative?
- Edwards Lifesciences commemorates 20 years in Singapore improving patients’ lives across Asia
- Edwards Lifesciences (NYSE:EW) Share Price Breaks Above Two Hundred Day Moving Average - What's Next?
- Barclays Starts Edwards Lifesciences (EW) at Overweight
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- What Does Expanded TAVR Coverage Mean for Edwards Lifesciences (NYSE:EW)?
- FDA Approves Edwards Lifesciences Autus Valve as First-Ever Expandable Pediatric Heart Valve
- Edwards Lifesciences (EW) Could Be 16% Undervalued As AUTUS Approval Sharpens The Debate
- Edwards Lifesciences wins FDA approval for AUTUS
- Edwards Wins FDA Approval for Expandable Pediatric Heart Valve
- Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
- JPMorgan Adjusts Price Target on Edwards Lifesciences to $105 From $100, Keeps Overweight Rating
- Edwards’ adjustable heart valve for children lands FDA approval
- A heart valve that grows with children shows what pediatric devices can become
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Edwards Lifesciences?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares